コンテンツへスキップ
Merck

232A-7

Sigma-Aldrich

カルレチニン

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352202
NACRES:
NA.41

由来生物

rabbit

結合体

unconjugated

抗体製品の状態

Ig fraction of antiserum

抗体製品タイプ

primary antibodies

クローン

polyclonal

詳細

For In Vitro Diagnostic Use in Select Regions (See Chart)

フォーム

buffered aqueous solution

化学種の反応性

human

包装

vial of 0.1 mL concentrate (232A-74)
vial of 0.5 mL concentrate (232A-75)
bottle of 1.0 mL predilute (232A-77)
vial of 1.0 mL concentrate (232A-76)
bottle of 7.0 mL predilute (232A-78)

メーカー/製品名

Cell Marque®

テクニック

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:500

コントロール

mesothelioma

輸送温度

wet ice

保管温度

2-8°C

視覚化

cytoplasmic, nuclear

詳細

Anti-calretinin has been shown to be useful in differentiating mesothelioma from adenocarcinomas from the lung and other sources.

品質


IVD

IVD

IVD

RUO

関連事項

Calretinin Positive Control Slides, Product No. 232S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

物理的形状

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

調製ノート

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

その他情報

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

法的情報

Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany

適切な製品が見つかりませんか。  

製品選択ツール.をお試しください

保管分類コード

12 - Non Combustible Liquids

WGK

WGK 2

引火点(℃)

Not applicable


最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

M C Barberis et al.
Acta cytologica, 41(6), 1757-1761 (1997-12-09)
To document that a polyclonal antiserum to calretinin, a 29-kd calcium-binding protein, consistently decorates normal and tumor mesothelial cells in cytologic preparations. Thirty-three archival cytologic specimens from eight patients with histologically confirmed malignant mesothelioma and 13 from patients with metastatic
N G Ordóñez
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 11(10), 929-933 (1998-10-31)
Only recently have immunohistochemical markers been recognized that are commonly expressed in epithelial mesotheliomas but not in adenocarcinomas. Among these, calretinin generated a great deal of interest, but the number of studies evaluating the practical use of calretinin immunostaining in
M P Leers et al.
Histopathology, 32(3), 209-216 (1998-05-06)
To assess the diagnostic accuracy of combinations of antibodies in the differential diagnosis of metastatic carcinomas and mesotheliomas in pleural lesions. The specificity and sensitivity of the commercially available antibodies Ber-EP4, MOC-31, CEA, B72.3, CD15, E-cadherin and calretinin were evaluated
R L Attanoos et al.
Histopathology, 39(6), 584-588 (2002-03-21)
Malignant epithelioid mesothelioma shows marked cytoarchitectural diversity. The aim of the study was to evaluate how immunoreactivity with mesothelial markers related to histological pattern. Ninety-two cases of malignant epithelioid mesothelioma (60 pleural, 32 peritoneal) were examined and classified as exhibiting
Merce Jorda et al.
Applied immunohistochemistry & molecular morphology : AIMM, 10(1), 67-70 (2002-03-15)
Most adrenocortical neoplasms and pheochromocytomas can be diagnosed by a combination of clinical findings and morphologic features. Occasionally, however, this histologic differential diagnosis requires ancillary tests, such as immunohistochemistry. Both tumors are generally negative for epithelial markers but express synaptophysin.

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)